-
Integrating Patient Perspectives Into Drug Reimbursement Decisions: Insights From Taiwan’s Deliberative HTA Process
Sep 9, 2025, 16:22 PM -
Developing an HER-Based Multifeature Machine Learning Model to Identify Lung Cancer Subtype
Sep 9, 2025, 16:22 PM -
Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Substudy
Sep 9, 2025, 16:22 PM -
Digital Health Technologies Assessment Based on Patient-Reported Outcome Measures (PROMs): Virtual Reality (VR) in the Treatment of Specific Phobias
Sep 9, 2025, 16:22 PM -
Real-World–Based Cost-Effectiveness of Lipid-Lowering Therapies for ASCVD Patients With High CV Risk in Taiwan
Sep 9, 2025, 16:22 PM -
Budget Impact of Introducing Accuchek® Smartguide Real-Time Continuous Glucose Monitoring (RtCGM) Solution for Diabetes Management in Portugal
Sep 9, 2025, 16:22 PM -
Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in the Netherlands: Insights From CHOICE-CSU 2 Study
Sep 9, 2025, 16:22 PM -
Optimizing Colorectal Cancer Screening in the Czech Republic: Cost-Effectiveness of Lowering the Starting Age to 45 and Introducing an Upper Limit
Sep 9, 2025, 16:22 PM -
Improving Kidney Exchange Program Effectiveness and Equity by Using Allele and Eplet HLA Compatibility Technologies
Sep 9, 2025, 16:22 PM -
Trends and Tensions in NICE Severity Modifiers: Analyzing the Acceptance and Critique of Manufacturer Severity Modifier Proposals in Recent Appraisals
Sep 9, 2025, 16:22 PM -
Budget Impact of Anakinra in Turkiye: An Analysis From the Social Security Institution’s Perspective
Sep 9, 2025, 16:22 PM -
Single-Arm Trials and Reimbursement Decision Making in Europe: A Case Study in Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Imlifidase Idefirix® for Desensitization Treatment of Highly Sensitized Adult Kidney Transplant Patients in Ireland
Sep 9, 2025, 16:22 PM -
Deep Brain Stimulation: A Cost-Saving Treatment Option for Extreme Treatment-Refractory Obsessive-Compulsive Disorder in the UK?
Sep 9, 2025, 16:22 PM -
Detection of a Potential Pericarditis Safety Signal Associated With Azithromycin: Evidence From FAERS Disproportionality Analysis
Sep 9, 2025, 16:22 PM -
Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study
Sep 9, 2025, 16:22 PM -
Historical Shifts in Birth Month Distribution in Japan and the Impacts on Health Outcome Studies
Sep 9, 2025, 16:22 PM -
The Health Economic Case for AI in Radiology: A Systematic Review and Appraisal of Evaluation Quality and Methods
Sep 9, 2025, 16:22 PM -
AI Powered SQL for Real-World Data: From Questions to Insights
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use of Peritoneal Dialysis Alone and Compared to Other Management Options for End-Stage Kidney Disease: Systematic Review of UK Evidence
Sep 9, 2025, 16:22 PM